LARKSPUR, Calif., March 21, 2022–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, has shared new preclinical data demonstrating solid tumor elimination when dosing AU-007, a monoclonal antibody computationally designed by Biolojic Design. Data were presented at a recent antibody biology and engineering conference.
Read more here.
![[Beyond Meat in Globe Newswire] Beyond IV, the fourth generation of the Beyond Burger® and Beyond Beef®, debuts at grocery stores across the U.S. including at Walmart and Kroger](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
